NKGen Biotech Inc. Common... (NKGN)

NASDAQ: NKGN · Real-Time Price · USD

0.17

0.02 (13.33%)

At close: Apr 29, 2025, 3:56 PM

NKGen Biotech Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	8K	79K	284K	276K	8.79M	41.46K	206.8K	635.15K	728.01K	1.26M	1.44M	1.72M	1.89M	2.01M	n/a
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	10.39M	18.29M	32.91M	63.53M	175.38M	173.49M	172.73M	171.82M	171.7M	171.66M	171.64M	171.62M	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	-32.91M	n/a	n/a	-15.98M	-1	n/a	n/a	n/a	n/a	n/a	279.53K
Receivables	24K	23K	26K	26K	41K	n/a	n/a	96K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	1.45M	n/a	n/a	-96K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	229K	274K	297K	313K	72K	34.18K	88.37K	4K	418.57K	537.7K	661K	812.72K	952.55K	1.11M	n/a
Total Current Assets	911K	1.25M	1.61M	1.93M	10.35M	75.64K	295.17K	877.91K	1.15M	1.8M	2.1M	2.54M	2.85M	3.12M	n/a
Property-Plant & Equipment	13.99M	14.31M	14.62M	14.46M	14.76M	n/a	n/a	15.88M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	93K	93K	91K	92K	90K	n/a	n/a	97K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	14.08M	14.4M	25.1M	32.84M	14.85M	63.53M	175.38M	173.49M	172.73M	171.84M	171.7M	171.66M	171.64M	171.62M	279.53K
Total Assets	14.99M	15.65M	26.7M	34.77M	25.2M	63.61M	175.68M	174.37M	173.88M	173.64M	173.8M	174.19M	174.48M	174.74M	279.53K
Account Payables	13.45M	12.69M	12.84M	11.04M	7.94M	n/a	n/a	975K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	5.19M	n/a	n/a	-12.83M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	19.7M	17.27M	11.56M	9.99M	5.23M	416.71K	n/a	11.65M	n/a	n/a	n/a	n/a	n/a	18.39K	62.98K
Other Current Liabilities	1.58M	19.59M	11.18M	16.77M	21.13M	5.89M	3.53M	-11.55M	2.77M	2.86M	2.19M	1.89M	798.73K	249.45K	227.22K
Total Current Liabilities	37.12M	51.41M	37.48M	39.45M	38.85M	6.3M	3.53M	2.85M	2.77M	2.86M	2.19M	1.89M	798.73K	267.84K	290.2K
Long-Term Debt	10.6M	10.37M	10.15M	9.93M	14.71M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	14.01M	23.24M	23.36M	25.76M	12.26M	3.05M	2.76M	n/a	2.81M	3.38M	8.89M	11.58M	11.63M	11.1M	n/a
Total Long-Term Liabilities	24.93M	33.96M	33.89M	35.72M	26.99M	3.05M	2.76M	2.53M	2.81M	3.38M	8.89M	11.58M	11.63M	17.1M	n/a
Total Liabilities	62.05M	85.36M	71.37M	75.17M	65.84M	9.35M	6.29M	5.37M	5.58M	6.23M	11.08M	13.47M	12.42M	17.37M	290.2K
Total Debt	30.74M	28.12M	22.21M	19.92M	20.03M	416.71K	n/a	12.03M	n/a	n/a	n/a	n/a	n/a	18.39K	62.98K
Common Stock	4K	3K	2K	2K	2K	62.8M	174.68M	173.16M	172.2M	171.62M	171.62M	171.62M	171.62M	152.37M	431.00
Retained Earnings	-177M	-183.6M	-167.51M	-162.13M	-128.52M	-8.54M	-5.3M	-4.17M	-3.91M	-4.21M	-8.89M	-10.9M	-9.56M	-4.35M	-35.67K
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	-47.05M	-69.72M	-44.67M	-40.4M	-40.64M	54.26M	169.38M	168.99M	168.29M	167.4M	162.72M	160.72M	162.06M	157.37M	-10.67K
Total Investments	n/a	n/a	10.39M	18.29M	32.91M	63.53M	175.38M	173.49M	172.73M	171.82M	171.7M	171.66M	171.64M	171.62M	n/a